北京大学学报(医学版) ›› 2016, Vol. 48 ›› Issue (6): 1032-1037. doi: 10.3969/j.issn.1671-167X.2016.06.019

• 论著 • 上一篇    下一篇

上尿路尿路上皮癌术前预后相关因素分析及初步风险分层模型构建

邢云超,熊耕砚,方东,张争,蔡林,张雷,何志嵩,李学松△,周利群△   

  1. (北京大学第一医院泌尿外科,北京大学泌尿外科研究所,国家泌尿、男性生殖系肿瘤研究中心,北京100034)
  • 出版日期:2016-12-18 发布日期:2016-12-18
  • 通讯作者: 李学松,周利群 E-mail: pineneedle@sina.com, zhoulqmail@sina.com
  • 基金资助:

    国家自然科学基金(81372746)、北京市自然科学基金(7152416)、首都临床特色应用研究与临床推广基金(Z151100004015173)和北京大学医学部与台湾大学医学合作研究项目基金(BMU20120318)资助

Preoperative prognostic factors and preoperative risk stratification of upper tract urothelial carcinoma

XING Yun-chao, XIONG Geng-yan, FANG Dong, ZHANG Zheng, CAI Lin, ZHANG Lei, HE Zhi-song, LI Xue-song△, ZHOU Li-qun△   

  1. (Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China)
  • Online:2016-12-18 Published:2016-12-18
  • Contact: LI Xue-song, ZHOU Li-qun E-mail: pineneedle@sina.com, zhoulqmail@sina.com
  • Supported by:

    Supported by the National Natural Science Foundation of China (81372746), the Beijing Natural Science Foundation (7152416), the Capital Foundation for Clinical Characteristics and Application Research (Z151100004015173), and the Medical Cooperative Research Project Fund of Peking University Health Science Center and Taiwan University (BMU20120318)

摘要:

目的:分析上尿路尿路上皮癌(upper tract urothelial carcinoma,UTUC)患者的术前预后因子,并构建适合中国患者的术前风险评估模型。方法:收集北京大学第一医院2003年至2013年的686例UTUC患者的临床和随访资料进行回顾性分析。结果:686例患者中,男性303例(44.2%),女性383例(55.8%),术后高分期(T3和T4)肿瘤203例(29.6%),高分级(G3)肿瘤300例(43.7%),淋巴结转移(N1)54例(7.9%),其中,肾盂肿瘤、肿瘤长径大于5 cm、肾小球滤过率(estimated glomerular filtration rate, eGFR)≥30 mL/min和男性与术后肿瘤高分期相关;输尿管肿瘤、肿瘤长径大于5 cm、没有吸烟史与术后肿瘤高分级相关;肾盂肿瘤、肿瘤长径大于5 cm和术前贫血与术后淋巴结转移相关。患者的平均随访时间65个月,其间有208例(30.3%)患者死于肿瘤,210例(30.6%)患者出现了膀胱复发,其中肿瘤长径大于5 cm(P=0.001)、伴随同侧肾积水(P=0.041)和术前贫血(P=0.001)是患者术后肿瘤特异性死亡的独立危险因子,输尿管肿瘤(P=0.04)、多发肿瘤(P=0.005)和术前血肌酐含量大于133 μmol/L(P=0.036)是患者术后膀胱复发的独立危险因素。结论:在UTUC患者常见的术前临床参数中,肿瘤长径大于5 cm、伴随同侧肾积水和术前贫血与术后肿瘤特异性生存呈独立相关,输尿管肿瘤、多发肿瘤和术前血肌酐大于133 μmol/L与术后膀胱复发呈独立相关。基于这些术前预后因素构建的中国患者术前风险分层系统,可以帮助临床医生在术前就对患者进行初步的风险评估,并指导后续的临床治疗。

关键词: 尿道上皮, 癌, 移行细胞, 肿瘤复发, 局部, 预后, 危险因素

Abstract:

Objective: To identify the preoperative prognostic factors of upper tract urothelial carcinoma (UTUC) and construct preoperative risk stratification system. Methods: A retrospective study including 686 patients who were diagnosed with UTUC and received radical nephroureterectomy or partial ureterectomy in Peking University First Hospital during 2003 and 2013. Results: Of the 686 UTUC patients, 303 (44.2%) were male and 383 (55.8%) female. The postoperative pathological examination showed that 203 (29.6%) had high tumor stages (T3, T4), 300 (43.7%) had high tumor grades (G3) and 54 (7.9%) had lymph nodes metastasis (N1). After multivariate analysis, renal pelvic tumor, large tumor, estimated glomerular filtration rate (eGFR) ≥30 mL/min, and male were associated with high tumor stage. Ureteral tumor, large tumor, and non-smoking history were associated with high tumor grade. Renal pelvis tumor, large tumor, and preoperative anemia were associated with positive N status. During the follow-up, 208 (30.3%) died for cancer and 210 (30.6%) developed intravesical recurrence. Multivariate analysis showed: large tumor (P=0.001), concomitant ipsilateral hydronephrosis (P=0.041), and preoperative anemia (P=0.001) were independently associated cancer-specific mortality after surgery, while ureteral tumor (P=0.04), multiple tumor (P=0.005), and high preoperative creatinine (P=0.036) were independent risk factors for intravesical recurrence. Conclusion: Of the preoperative clinical parameters of UTUC patients, the large tumor, concomitant ipsilateral hydronephrosis, and preoperative anemia were independently associated with cancer-specific mortality after surgery. Ureteral tumor, multiple tumor, and high preoperative creatinine were independently associated with intravesical recurrence after surgery.

Key words: Urothelium, Carcinoma, transitional cell, Neoplasm recurrence, local, Prognosis, Risk factors

中图分类号: 

  • R737.1
[1] 步召德, 冯梦宇, 季科. 早期胃癌行前哨淋巴结导航手术的实践与思考[J]. 北京大学学报(医学版), 2026, 58(2): 239-243.
[2] 王海, 江一舟. 靶向血管治疗在乳腺癌精准治疗中的分子机制与临床应用[J]. 北京大学学报(医学版), 2026, 58(2): 251-256.
[3] 罗必显, 刘洪铭, 谢伟勋, 龚渭华. 产甲胎蛋白胃癌的新临床特征和前沿科学问题[J]. 北京大学学报(医学版), 2026, 58(2): 257-265.
[4] 付浩, 申潞艳, 黄冰洋, 马少华. 免疫治疗背景下食管鳞状细胞癌围手术期治疗的临床思考[J]. 北京大学学报(医学版), 2026, 58(2): 266-271.
[5] 魏慧, 张警丰, 姚中强, 赵金霞. 类风湿关节炎合并慢性病贫血患者的临床特征及相关因素[J]. 北京大学学报(医学版), 2026, 58(2): 307-312.
[6] 赵杰, 付春, 赵秀娟, 薛海岩, 李纾, 王振洲, 朱凤雪. 胸部创伤患者在重症监护病房内发生呼吸机相关性肺炎的危险因素[J]. 北京大学学报(医学版), 2026, 58(2): 351-358.
[7] 殷昊明, 王子杰, 舒帆, 张展奕, 梁会, 张树栋. 肾透明细胞癌FABP6基因长转录本的表达及意义[J]. 北京大学学报(医学版), 2026, 58(2): 393-398.
[8] 李嘉临, 陈力侨, 唐家天, 吴艳, 王安强. 胃肝样腺癌转化治疗1例[J]. 北京大学学报(医学版), 2026, 58(2): 399-404.
[9] 郭芷均, 俎明, 马超, 张贺军, 张静, 丁士刚. 同时性多发早期胃癌漏诊病灶的临床病理特征[J]. 北京大学学报(医学版), 2026, 58(2): 410-415.
[10] 潘子晨, 陈凯, 侯钰坤, 杨博涵, 张继新, 马永蔌, 田孝东, 杨尹默. 胰腺腺鳞癌临床病理特征与分子机制研究进展[J]. 北京大学学报(医学版), 2026, 58(2): 431-435.
[11] 张铃福, 陈明, 赵小宇, 王港, 崔龙, 凌晓锋, 王立新, 徐智, 郭丽梅, 侯纯升. 原发灶局限于胆囊壁内胆囊癌大体分型及其与预后和癌前病变的相关性[J]. 北京大学学报(医学版), 2026, 58(1): 184-189.
[12] 高雅静, 李正芳, 马梦思, 武丽君. SII和SIRI对白塞病葡萄膜炎的风险预测及疾病活动度和预后的评估[J]. 北京大学学报(医学版), 2025, 57(6): 1067-1073.
[13] 王晓林, 李璐瑶, 张雯, 王鸿雁. 3例子宫体中肾样腺癌的临床病理学分析[J]. 北京大学学报(医学版), 2025, 57(6): 1208-1212.
[14] 侯卫华, 宋书杰, 石中月, 刘露, 金木兰. 食管胃结合部具有显著空泡状核特征的神经内分泌癌1例[J]. 北京大学学报(医学版), 2025, 57(5): 1005-1009.
[15] 谢尚, 王鹿鸣, 张馨元, 冯秋实, 夏洋洋, 戴姿薇, 单小峰, 蔡志刚. 口腔鳞癌类器官库的构建及应用[J]. 北京大学学报(医学版), 2025, 57(5): 847-851.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!